| Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis ME Wechsler, P Akuthota, D Jayne, P Khoury, A Klion, CA Langford, ... New England Journal of Medicine 376 (20), 1921-1932, 2017 | 1129 | 2017 |
| Anti–Siglec-8 antibody for eosinophilic gastritis and duodenitis ES Dellon, KA Peterson, JA Murray, GW Falk, N Gonsalves, M Chehade, ... New England Journal of Medicine 383 (17), 1624-1634, 2020 | 279 | 2020 |
| Benralizumab for PDGFRA-Negative Hypereosinophilic Syndrome FL Kuang, F Legrand, M Makiya, JA Ware, L Wetzler, T Brown, T Magee, ... New England Journal of Medicine 380 (14), 1336-1346, 2019 | 218 | 2019 |
| Eosinophils in vasculitis: characteristics and roles in pathogenesis P Khoury, PC Grayson, AD Klion Nature Reviews Rheumatology 10 (8), 474-483, 2014 | 201 | 2014 |
| International consensus recommendations for eosinophilic gastrointestinal disease nomenclature ES Dellon, N Gonsalves, JP Abonia, JA Alexander, NC Arva, D Atkins, ... Clinical Gastroenterology and Hepatology 20 (11), 2474-2484. e3, 2022 | 188 | 2022 |
| Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitis J Steinfeld, ES Bradford, J Brown, S Mallett, SW Yancey, P Akuthota, ... Journal of Allergy and Clinical Immunology 143 (6), 2170-2177, 2019 | 140 | 2019 |
| A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions E Dellon, P Khoury, S ...Aceves Gastroenterology, 2022 | 138 | 2022 |
| Middleton's allergy E-Book: principles and practice AW Burks, RE O'Hehir, DH Broide, ST Holgate, LB Bacharier, ... Elsevier Health Sciences, 2019 | 135 | 2019 |
| Serum biomarkers are similar in C hurg–S trauss syndrome and hypereosinophilic syndrome P Khoury, P Zagallo, C Talar‐Williams, CS Santos, E Dinerman, ... Allergy 67 (9), 1149-1156, 2012 | 108 | 2012 |
| Eosinophils in health and disease JJ Lee, HF Rosenberg Elsevier, 2012 | 105 | 2012 |
| Long-term clinical outcomes of high-dose mepolizumab treatment for hypereosinophilic syndrome FL Kuang, MP Fay, JA Ware, L Wetzler, N Holland-Thomas, T Brown, ... The Journal of Allergy and Clinical Immunology: In Practice 6 (5), 1518-1527. e5, 2018 | 93 | 2018 |
| Marked and persistent eosinophilia in the absence of clinical manifestations YYK Chen, P Khoury, JAM Ware, NC Holland-Thomas, JL Stoddard, ... Journal of allergy and clinical immunology 133 (4), 1195-1202. e2, 2014 | 87 | 2014 |
| Episodic angioedema with eosinophilia (Gleich syndrome) is a multilineage cell cycling disorder P Khoury, J Herold, A Alpaugh, E Dinerman, N Holland-Thomas, ... haematologica 100 (3), 300, 2015 | 79 | 2015 |
| Hypereosinophilia in children and adults: a retrospective comparison KW Williams, JA Ware, A Abiodun, NC Holland-Thomas, P Khoury, ... The Journal of Allergy and Clinical Immunology: In Practice 4 (5), 941-947. e1, 2016 | 75 | 2016 |
| IL-5 receptor α levels in patients with marked eosinophilia or mastocytosis TM Wilson, I Maric, J Shukla, M Brown, C Santos, O Simakova, P Khoury, ... Journal of allergy and clinical immunology 128 (5), 1086-1092. e3, 2011 | 72 | 2011 |
| Hypereosinophilic syndrome subtype predicts responsiveness to glucocorticoids P Khoury, AO Abiodun, N Holland-Thomas, MP Fay, AD Klion The Journal of Allergy and Clinical Immunology: In Practice 6 (1), 190-195, 2018 | 70 | 2018 |
| Artificial intelligence: exploring the future of innovation in allergy immunology D MacMath, M Chen, P Khoury Current allergy and asthma reports 23 (6), 351-362, 2023 | 69 | 2023 |
| Clinical exome sequencing of 1000 families with complex immune phenotypes: toward comprehensive genomic evaluations MN Similuk, J Yan, R Ghosh, AJ Oler, LM Franco, MR Setzer, M Kamen, ... Journal of Allergy and Clinical Immunology 150 (4), 947-954, 2022 | 67 | 2022 |
| Benralizumab completely depletes gastrointestinal tissue eosinophils and improves symptoms in eosinophilic gastrointestinal disease FL Kuang, MS De Melo, M Makiya, S Kumar, T Brown, L Wetzler, ... The Journal of Allergy and Clinical Immunology: In Practice 10 (6), 1598 …, 2022 | 64 | 2022 |
| Dexpramipexole as an oral steroid-sparing agent in hypereosinophilic syndromes SR Panch, ME Bozik, T Brown, M Makiya, C Prussin, DG Archibald, ... Blood, The Journal of the American Society of Hematology 132 (5), 501-509, 2018 | 64 | 2018 |
